AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Companies aim for 'deep pockets' at BIO's VentureForum conference.
October 7, 2002... More than 300 investors held tight to their money clips and browsed the Palace Hotel in San Francisco last week, shopping for a share in biotechnology's best and brightest companies.
A total of 130 private companies gave 10-minute pitches...
Money raised by biotech in 2002 vs. 2001.
October 7, 2002...
Money Raised By Biotech In 2002 Vs. 2001
Millions
Jan. 1-October 3, Jan. 1-October 4,
2002: $8,768.41M 2001: $9,179.29M
Public/Other * 4,951 ...
10 biggest U.S. gainers for the week.
October 7, 2002...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent)
Neo Therapeutics 70.00
Axonyx 50.94
Generex Biotech 40.00
Biopure 36.26
Cytogen 34.04
Photogen 24.44
Paradigm Genetics...
10 biggest U.S. losers for the week.
October 7, 2002...
10 BIGGEST U.S. LOSERS FOR THE WEEK
(By Percent)
IntraBiotics -75.80
Transkaryotic -60.44
Valentis -53.13
Osteotech -41.70
Biomira -38.46
Aphton -37.16
Sheffield...
Corrections.
October 7, 2002... A story in the Sept. 30, 2002, issue of Bio World Financial Watch should have specified that Genzyme General's deal with BioMarin Pharmaceutical Inc. is to develop Aldurazyme--a treatment for mucopolysaccharidosis 1--and not any treatments for...
Public financing of biotechnology: September 2002.
October 7, 2002...
Public Financing Of Biotechnology: September 2002
I. COMMENCED TRADING IN SEPTEMBER
Company Date Date Shares/ Price
(Symbol) Filed Comm. Units (M)
INITIAL...
Other financings of Public Biotechnology Companies: September 2002.
October 7, 2002...
Other Financings Of Public Biotechnology Companies: September 2002
TOTAL: $78.645M
Company Type Of Number Of Amount
(Symbol) # Financing Shares, Units Raised
...
Venture capital and Corporate Investments in Biotechnology Companies.
October 7, 2002...
Venture Capital And Corporate Investments In Biotechnology Companies:
September 2002
1. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $277.15M
Company Location Date Amt. (M)
Alexza MDC Palo Alto,...
Money raised by biotech.
October 7, 2002...
Money Raised By Biotech In 2002: January-September
Type of I ($M) F ($M) M ($M) A ($M) M ($M) J ($M)
financing
Public offerings 75.1 345.8 156.9 325.0 21.8 69.6
Private biotechs 341.0 241.6...
BioWorld stock report for Public Biotechnology Companies.
October 7, 2002...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close Change
9/27 10/4 WK YTD
3D Pharma DDDP 2.969 3.21 ...
London Stock Exchange.
October 7, 2002...
LONDON STOCK EXCHANGE
Company Symbol 9/27 10/4 %WK %YTD Volume
Acambis ACM 239 243 1.67 -30.67 1488
Antisoma ASM 11.75 12.25 4.26 -65.49 1237
British Biotech ...
Toronto Stock Exchange.
October 7, 2002...
TORONTO STOCK EXCHANGE
Company Symbol 9/27 10/4 %WK %YTD Volume
Adherex AHX 0.43 0.42 -2.33 0.00 129
Angiotech Pharma ANP 63.14 56.2 -10.99 -36.85 675
Anormed ...
Pozen's migraine drug answers pained call for new tablet.
October 14, 2002... There may be some doubt about what's just "a bad headache" and what's a migraine, but those who suffer the latter are absolutely sure what they're feeling. Often, their initial clue is the dreaded "prodrome," a sense that the migraine is about...
Money raised by biotech in 2002 vs. 2001.
October 14, 2002...
Money Raised by Biotech In 2002 Vs. 2001
Millions
Jan. 1 - October 10 Jan. 1 - October 11
2002: $8,822.86M 2001: $9,714.19M
Public/Other * 4,952...
10 biggest U.S. gainers for the week.
October 14, 2002...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent)
Synsorb Biotech 50.00
Emisphere 35.52
Qiagen 30.16
Hycor Bio 29.70
Transgene 25.49
Aphton 25.00
Biomira ...
10 biggest U.S. losers for the week.
October 14, 2002...
10 BIGGEST U.S. LOSERS FOR THE WEEK
(By Percent)
Adv Tissue Sci -91.60
Northwest BioThera -60.00
Photogen -51.79
MacroChem -51.65
Cholestech -42.06
DOR BioPharma -37.50
Cytogen ...
Clinical trial update: September 2002.
October 14, 2002...
Clinical Trial Update: September 20
Company * Product Description
(Country;
Symbol)
AUTOIMMUNE
Angiotech Paxceed Micellar paclitaxel for
Pharmaceuticals ...
Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: September 2002.
October 14, 2002...
Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And
Approvals: September 2002
Company * Product
(Country;
Symbol)
AUTOIMMUNE
Tularik Inc. T487
(TLRK) and Chemo-...
FDA submissions, approvals and other actions: September 2002.
October 14, 2002...
FDA Submissions, Approvals And Other Actions: September 2002
AUTOIMMUNE
Company * Product Description
(Country;
Symbol)
Biogen Inc. Amevive Alefacept; novel immuno-
(BGEN) ...
BioWorld stock report for Public Biotechnology Companies.
October 14, 2002...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close % Change
10/04 10/11 WK YTD
3D Pharma DDDP 3.21 2.92 ...
London Stock Exchange.
October 14, 2002...
LONDON STOCK EXCHANGE
Company Symbol 10/04 10/11 %WK %YTD Volume
Acambis ACM 243 239 -1.65 -31.81 6295
Antisoma ASM 12.25 12 -2.04 -66.20 211
British Biotech BBG...
Toronto Stock Exchange.
October 14, 2002...
TORONTO STOCK EXCHANGE
Company Symbol 10/04 10/11 %WK %YTD Volume
Adherex AHX 0.42 0.41 -2.38 -2.38 220
Angiotech Pharma ANP 56.2 53.25 -5.25 -40.17 364
Anormed ...
Europeans eager to surpass U.S. as biotechnology leader.
October 21, 2002... LILLE, France -- Lille is the fourth largest city in France. It is north of Paris and quite near Brussels, Belgium, all the while being a relatively short train ride from London. Its locale has given the city the honor of being a crossroads....
Money raised by biotech in 2002 vs. 2001.
October 21, 2002...
Money Raised By Biotech In 2002 Vs. 2001
Millions
Jan. 1 - Oct. 17, Jan. 1 - Oct. 18,
2002: $8,836.28M 2001: $9,880.39M
Public/Others * 4,952 ...
10 biggest U.S. gainers & losers for the week.
October 21, 2002...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent) (By Dollars)
InFormax 124.07 Genzyme 4.88
Interleukin 114.39 Biogen 4.85
Immune Resp 66.67 IDEC Pharma 4.75...
Biotech mergers and acquisitions.
October 21, 2002...
Biotech Mergers And Acquisitions: July 20 - Oct. 16, 2002 #
I. COMPLETED MERGERS AND ACQUISITIONS
Company Acquired By
Acquired * Or Merged With *
(Country; Symbol) (Country;...
BioWorld stock report for public biotechnology companies.
October 21, 2002...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close % Change Vol
10/11 10/18 WK YTD (000)
3D Pharma DDDP 2.92 2.9 ...
London Stock Exchange.
October 21, 2002...
LONDON STOCK EXCHANGE
Company Symbol 10/11 10/18 %WK %YTD Volume
Acambis ACM 239 226.5 -5.23 -35.38 4784
Antisoma ASM 12 11.75 -2.08 -66.90 476
British Biotech BBG ...
Toronto Stock Exchange.
October 21, 2002...
TORONTO STOCK EXCHANGE
Company Symbol 10/11 10/18 %WK %YTD Volume
Adherex AHX 0.41 0.4 -2.44 -4.76 102
Angiotech Pharma ANP 53.25 55.75 4.69 -37.36 127
Anormed ...
Amgen girds for competition in high-stakes RA therapy field.
October 28, 2002... A longstanding squabble between Amgen Inc. and Johnson & Johnson over epoetin alfa ended last week with an arbitrator's $150 million decision favoring the former, just as another skirmish - not legal - began to heat up between the pair.
...
Money raised by biotech in 2002 vs. 2001.
October 28, 2002...
Money Raised By Biotech In 2002 Vs. 2001
Millions
Jan. 1 - October 24, Jan. 1 - October 25,
2002: $8,867.82M 2001: $10,264.4M
Public/Other * ...
10 biggest U.S. losers for the week.
October 28, 2002...
10 BIGGEST U.S. LOSERS FOR THE WEEK
(By Percent)
BioTransplant -62.28
Alliance -52.78
Northwest BioThera -36.11
British Biotech -33.33
Texas Biotech -20.28
Vion Pharma -19.35...
10 biggest U.S. gainers for the week.
October 28, 2002...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent)
Photogen 106.25
Biomira 68.75
Viragen 64.71
NeoRx Corp. 55.21
NaPro Biother 55.20
Targeted Genetics 50.00
Sepracor ...
Correction.
October 28, 2002... The Oct. 21, 2002, issue of BioWorld Financial Watch contained incorrect dates on the column headers for the stock prices on pages 7 and 8. The correct dates were Oct. 11 and 18.
Editor's note: The changes have been made in BioWorld Online....
Biotech -- big pharma collaborations: new agreements, Sept. 18 -- Oct. 23, 2002 #.
October 28, 2002...
Biotech-Big Pharma Collaborations: New Agreements, Sept. 18--Oct. 23,
2002 #.
Biotech Co, * Pharma Co.
(Country; (Country)
Symbol)
20/20 Gene- Novartis AG
Systems Inc. * (Switzerland)
...
Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: Sept. 18 -- Oct. 23 2002 #.
October 28, 2002...
Manufacturing, Marketing And Distribution Agreements Between Biotech And
Pharmaceutical Companies: Sept. 18 -- Oct. 23, 2002 #
Biotech Co. * Pharma Co. Product
(Country; (Country)
Symbol)
...
Biotech -- big pharma collaborations: modified and terminated agreements, Sept. 18 -- Oct. 23, 2002 #.
October 28, 2002...
Biotech--Big Pharma Collaborations: Modified And Terminated agreements,
Sept. 18 -- Oct. 23, 2002 *.
I. MODIFIED AGREEMENTS
Biotech Co. * Pharma Co.
(Country; (Country)
Symbol)
Accelrys Inc. ...
Bioworld stock report for public biotechnology companies.
October 28, 2002...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close %Change
10/18 10/25 WK YTD
3D Pharma DDDP 2.9 2.94 ...
London stock exchange.
October 28, 2002...
LONDON STOCK EXCHANGE
Company Symbol 10/18 10/25 %WK %YTD Volume
Acambis ACM 226.5 255.5 12.80 -27.10 2424
Antisoma ASM 11.75 12.5 6.38 -64.79 924
British Biotech BBG...
Toronto stock exchange.
October 28, 2002...
TORONTO STOCK EXCHANGE
Company Symbol 10/18 10/25 %WK %YTD Volume
Adherex AHX 0.4 0.365 -8.75 -13.10 133
Angiotech Pharma ANP 55.75 61.73 10.73 -30.64 95
Anormed ...